top of page

The purpose of this webpage and subsequent document is to provide information to existing and prospective investors, and potential commercial partners, about the current status of BCAL’s research and development. It is not intended to promote the use or supply of any therapeutic goods.

Our News

MST page 1 Dec22_edited_edited.jpg

Research report: MST Access updates BCAL coverage

14 December, 2022

bottom of page